Newsroom
Sorted by: Latest
-
Savara Announces the U.S. Food and Drug Administration (FDA) Filed the MOLBREEVI* Biologics License Application (BLA) in Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP)
LANGHORNE, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA) (the Company), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, announced the FDA has filed for review the BLA for MOLBREEVI as a therapy to treat patients with autoimmune PAP. The FDA granted Priority Review with a PDUFA action date of August 22, 2026. “The FDA’s filing of the BLA marks another significant milestone for Savara and the autoimmune PAP community and brings us one step closer to a potential...
-
Helix to Participate in Upcoming Events
HOUSTON--(BUSINESS WIRE)--Helix Energy Solutions Group, Inc. (NYSE: HLX) announced today that it will participate in the following upcoming events: Daniel Energy Partners THRIVE Energy Conference in Houston, Texas at Daikin Park on Wednesday, February 25, 2026 Raymond James & Associates 47th Annual Institutional Investor Conference in Orlando, Florida at the JW Marriott Orlando Grande Lakes on Tuesday, March 3, 2026 Piper Sandler 26th Annual Energy Conference in Las Vegas, Nevada at the Wal...
-
Westlake Corporation Declares Quarterly Dividend
HOUSTON--(BUSINESS WIRE)--The Board of Directors of Westlake Corporation (NYSE: WLK) today declared a regular dividend distribution of $0.53 per share for the fourth quarter of 2025. This dividend will be payable on March 18, 2026 to stockholders of record on March 3, 2026. Westlake announced its first dividend on November 11, 2004 and has successively been paying and increasing its dividend for the past 22 years. The statements in this release that are not historical facts, including statement...
-
Chatham Lodging Announces Date of 2026 Annual Meeting of Shareholders
WEST PALM BEACH, Fla.--(BUSINESS WIRE)--Chatham Lodging Announces Date of 2026 Annual Meeting of Shareholders...
-
AM Best Upgrades Financial Strength Rating to A++ (Superior) and Revises Outlook to Stable for RLI Corp., RLI Insurance Co., Mt. Hawley Insurance Co. and Contractors Bonding and Insurance Co.
PEORIA, Ill.--(BUSINESS WIRE)--RLI Corp. announces AM Best has upgraded its financial strength rating to A++ Superior....
-
Nuveen Real Asset Income and Growth Fund Declares Distribution
CHICAGO--(BUSINESS WIRE)--The Nuveen Real Asset Income and Growth Fund (NYSE: JRI) has declared its regular monthly distribution with a record date of March 2, 2026, payable April 1, 2026. As previously announced, the Board of Trustees (the “Board”) has approved the terms of the issuance of transferable rights (“Rights”) to the holders of the Fund’s common shares (par value $.01 per share) (“Common Shares”) as of February 6, 2026 (the “Record Date”). The Rights offering will expire at 5:00 p.m....
-
Box to Present at Investor Conference
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Box (NYSE: BOX), the leading Intelligent Content Management (ICM) platform, today announced that members of its management team will present at the following conference: Morgan Stanley Technology, Media & Telecom Conference Date and Time: March 4, 2026 at 2:35pm PT Location: San Francisco, CA This event will be webcast live at boxinvestorrelations.com, and the replay will be available approximately twelve hours after the live event. The conference repl...
-
Nakamoto Inc. Completes Acquisition of BTC Inc and UTXO Management
NASHVILLE, Tenn.--(BUSINESS WIRE)--Nakamoto Inc. (NASDAQ: NAKA) (“Nakamoto” or the “Company”), today announced the successful completion of its previously announced acquisitions of BTC Inc, the leading provider of Bitcoin-related media and events, and UTXO Management GP, LLC (“UTXO”), an investment firm focused on private and public Bitcoin companies (collectively, the “Transaction”), following the satisfaction of customary closing conditions. With the completion of the Transaction, BTC Inc and...
-
Exact Sciences Stockholders Approve Acquisition by Abbott
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE: ABT) at the special meeting of stockholders held earlier today. At the special meeting, preliminary results showed that more than 99% of the votes cast, representing approximately 67% of the total outstanding shares of Exact Scie...
-
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced that the Compensation Committee of its Board of Directors has granted equity awards to two new employees as equity inducement awards outside of the Company's 2017 Equity Incentive Plan, but under the terms of the 2017 Inducement Equity Incentive Plan. The equity awards were appro...